Groundbreaking of New Gleneagles Hong Kong Hospital

20140113_groundbreaking_photo_upload.jpg#asset:3530:url

(from left) Patrick Lam, Executive Director of NWS Holdings, Professor Roland Chin, Deputy Vice-Chancellor and Provost of The University of Hong Kong, Dr Tan See Leng, Managing Director and Chief Executive Officer of IHH Healthcare Berhad and Group Chief Executive Officer and Managing Director of Parkway Pantai, Dr Henry Cheng, Chairman and Executive Director of New World Development Company Limited, Tan Sri Dato’ Dr Abu Bakar Bin Suleiman, Chairman of IHH Healthcare Berhad, Dato’ Mohammed Azlan Bin Hashim, Chairman of Parkway Pantai, Tsang Yam Pui, Executive Director of NWS Holdings, Dr Kok Mun Foong, Chief Executive Officer of the GHK Hospital Limited and Brian Cheng, Executive Director of NWS Holdings officiate at the groundbreaking ceremony.


(January 13, 2014 – Hong Kong) Representatives from Parkway Pantai Limited (“Parkway Pantai”), NWS Holdings Limited (“NWS Holdings”; Hong Kong stock code: 659) and The University of Hong Kong (“HKU”) officiated the groundbreaking ceremony of the Gleneagles Hong Kong Hospital on 10 January (Friday). The Hospital, scheduled for operation in early 2017, will provide high quality and affordable clinical services to the Hong Kong community.

The project was first announced in March last year when GHK Hospital Limited (“GHK”) successfully won the bid to design and construct a private hospital at Wong Chuk Hang, Hong Kong. The new 500-bed hospital will provide high quality clinical services with a transparent fee structure that are accessible and affordable to the Hong Kong community. It also aims to leverage the best clinical and management expertise to address the healthcare needs of the Hong Kong community, with a focus on the training of healthcare professionals and the advancement of clinical and research excellence.

GHK is a partnership between Parkway Pantai and NWS Holdings, the infrastructure and service flagship of the New World Group, with the participation of HKU as the clinical partner.

“Parkway Pantai is committed to the people and future of healthcare in Hong Kong,” says Dato’ Mohammed Azlan bin Hashim, Chairman of Parkway Pantai. “We will do our best to develop all facets of the sector from the provision of affordable healthcare to domestic patients to the training of doctors. With more than 30 years’ experience in managing worldclass hospitals, we see an opportunity to alleviate the pent-up demand for quality healthcare in Hong Kong, replicating the success experience in Singapore which has similar demographics.”

Dr Henry Cheng, Chairman and Executive Director of New World Development Company Limited and Chairman of NWS Holdings, says, “The Gleneagles Hong Kong Hospital marks a key milestone in the development of a high quality, patient-centred healthcare system in Hong Kong. We are committed to supporting the needs of Hong Kong people and contributing to the local healthcare industry. With our expertise and track record in hospital construction and services, we strive to ensure the successful construction and implementation of the Gleneagles Hospital.”

Professor Roland Chin, Deputy Vice Chancellor and Provost of The University of Hong Kong, says, “The University of Hong Kong looks forward to training Hong Kong’s future doctors, nurses, pharmacists and Chinese medicine practitioners in this new, our third, affiliate teaching hospital. The Gleneagles Hong Kong Hospital will also provide an important research base for translational science and discovery. Our colleagues at the Li Ka Shing Faculty of Medicine will bring to bear their superlative experience in clinical governance thereby ensuring excellent quality care at the hospital.”

About Gleneagles Hong Kong Hospital

Gleneagles Hong Kong Hospital will provide a full range of clinical services with more than 15 specialties (including general medicine, general surgery, orthopaedics and traumatology, gynaecology and others) and a total capacity of 500 beds. Over 50% of the inpatient bed days will be charged at packaged rates based on Diagnosis-Related Groups (DRG). The Hospital will have a transparent system for packages and fees, so that patients’ concerns about financial uncertainties can be minimised. Occupying a gross floor area of 46,750 square metres, the Hospital is scheduled for operation in early 2017. With strong credentials, commitment and the experience of the three partners, it will have state-of-the-art clinical equipment and a team of healthcare professionals at a level of international excellence.

About Parkway Pantai Limited

Parkway Pantai Limited, part of the IHH Healthcare Berhad group, is one of the region’s largest integrated private healthcare groups with a network of 18 hospitals and more than 3,500 beds throughout Asia, including Singapore, Malaysia, Brunei, India, China and Vietnam. From 2014 onwards, the Group will have 7 new hospitals with more than 2,000 additional beds. In Singapore, the Group operates a suite of Singapore’s premier private hospitals: Mount Elizabeth Novena Hospital, Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital – all accredited by Joint Commission International (JCI). It also owns Parkway Shenton, a large network of primary healthcare clinics and services, ParkwayHealth Radiology and ParkwayHealth Laboratory. In Malaysia, the Group owns and operates nine Pantai Hospitals, two Gleneagles Hospitals and ancillary healthcare services including Pantai Integrated Rehab and Pantai Premier Pathology. Parkway Pantai Limited also operates more than 20 patient assistance centres across the globe, providing patients with seamless patient care and a one-stop referral source to its hospitals and services. For more information, please visit the website at www.parkwaypantai.com.

About NWS Holdings Limited

NWS Holdings Limited (“NWS Holdings”, Hong Kong stock code: 659), the infrastructure and service flagship of New World Development Company Limited (Hong Kong stock code: 17), operates businesses in Hong Kong, Mainland China and Macau. Its Infrastructure portfolio includes Roads, Energy, Water and Ports & Logistics projects. Its Services portfolio comprises Facilities Management (the management of Hong Kong Convention and Exhibition Centre and Free Duty), Construction & Transport (construction and bus and ferry services) and Strategic Investments. For more information, please visit www.nws.com.hk/.

About The University of Hong Kong

The Li Ka Shing Faculty of Medicine, The University of Hong Kong is the oldest local institution of higher education. It was founded as the Hong Kong College of Medicine for Chinese in 1887, was renamed as the Hong Kong College of Medicine in 1907 and became the premier founding Faculty when the University was established in 1911. From its modest beginnings, the Faculty has grown to become the largest faculty of the University, with 300 full-time teaching staff and 600 research support personnel. The undergraduate student population is about 2,000 and postgraduates number 1,300. The Faculty is comprised of 17 departments, School of Chinese Medicine, School of Nursing, School of Public Health and a number of strategic centres of research excellence. For more information, please visit www.med.hku.hk.